Search results for "Myasthenia"

showing 6 items of 56 documents

Dropped head as an unusual presenting sign of myasthenia gravis.

2007

Prominent or isolated weakness of cervical extensor muscles is a relatively rare clinical sign. Commonly, this is known as "dropped-head syndrome". This abnormal flexion of the head may occur in a variety of neuromuscular diseases and in a few non-neurological disorders as well. The case we describe concerns a 61-year-old woman with dropped-head syndrome as the unique complaint of myasthenia gravis.

medicine.medical_specialtyWeaknessNeurologyAbnormal flexionDermatologyNeck MusclesMyasthenia GravismedicineHumansNeuroradiologyMuscle Weaknessbusiness.industryGeneral MedicineRecovery of FunctionMiddle Agedmedicine.diseaseDermatologyMagnetic Resonance ImagingMyasthenia gravisPsychiatry and Mental healthTreatment OutcomeDropped headCervical VertebraeFemaleNeurology (clinical)NeurosurgeryCholinesterase Inhibitorsmedicine.symptombusinessHeadSign (mathematics)Pyridostigmine BromideNeurological sciences : official journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology
researchProduct

Immune-mediated rippling muscle disease with myasthenia gravis: a report of seven patients with long-term follow-up in two.

2009

We report seven patients with immune-mediated rippling muscle disease (iRMD) and AChR-antibody positive myasthenia gravis (MG) without germline caveolin-3 gene mutations. We describe the follow-up of two patients and the clinical features of five new patients (1 female, 4 male, aged 32 to 69 years). These presented with significant generalized, exercise-induced and electrically-silent muscle rippling with myalgia, combined with generalized MG. In two of the seven patients, MG appeared before iRMD. Mediastinal imaging excluded thymic alterations in all, although two had other coincident tumours. Myalgia and rippling were aggravated by acetylcholinesterase-inhibitor treatment. Generalized MG …

myalgiaAdultMalePathologymedicine.medical_specialtyCaveolin 3Immunogenicmedicine.medical_treatmentMuscle Fibers SkeletalMuscle ProteinsCaveolin-3; Immunogenic; Myasthenia gravis; Rippling muscle disease; TherapyAzathioprineThymus GlandGene mutationBiologyCaveolaeDysferlinCaveolin-3Muscular DiseasesAzathioprineMyasthenia GravismedicineHumansMuscle SkeletalGenetics (clinical)AgedAutoantibodiesSarcolemmaElectromyographyAutoantibodyRippling muscle diseasePlasmapheresisMiddle Agedmedicine.diseaseMyasthenia gravisNeurologyPediatrics Perinatology and Child Healthbiology.proteinPlasmapheresisFemaleSteroidsTherapyNeurology (clinical)Cholinesterase Inhibitorsmedicine.symptommedicine.drugFollow-Up StudiesMuscle ContractionNeuromuscular disorders : NMD
researchProduct

Frequency and Correlates of Mild Cognitive Impairment in Myasthenia Gravis

2023

Background: Antibodies against acetylcholine receptors (AChRs) can also target nicotinic AChRs that are present throughout the central nervous system, thus leading to cognitive dysfunctions in patients with myasthenia gravis (MG). However, the presence of cognitive impairment in MG is controversial, and the factors that may influence this risk are almost completely unknown. In this study, the frequency of mild cognitive impairment (MCI) in MG, as well as the clinical, immunological, and behavioral correlates of MCI in MG were evaluated. Methods: A total of 52 patients with MG underwent a comprehensive assessment including motor and functional scales, serological testing, and neuropsychologi…

myasthenia gravisdepressive symptomsGeneral NeuroscienceprevalenceSettore MED/26 - Neurologiasleep disordersneuropsychological testingcognitive impairmentBrain Sciences
researchProduct

Impact of COVID-19 in AChR Myasthenia Gravis and the Safety of Vaccines: Data from an Italian Cohort.

2022

Background and aims. Patients with Myasthenia gravis (MG) are considered vulnerable as they may present with respiratory muscle weakness and because they are on immunosuppressive treatment; thereby, COVID-19 may have a detrimental effect on these patients. Vaccines against COVID-19 are currently available and it has been shown as they can prevent severe COVID-19 in vulnerable patients. Notwithstanding their efficacy, vaccine hesitancy has not been completely dispelled in the general population. Unfortunately, there is limited data about the safety of these vaccines in MG patients. The aims of this study are to evaluate the impact of COVID-19 in a MG cohort, the adherence to COVID-19 vaccina…

myasthenic crisisvaccineCOVID-19; SARS-CoV2; vaccine; Myasthenia gravis; neuromuscular; myasthenic crisisSARS-CoV2COVID-19neuromuscularNeurology (clinical)Myasthenia gravisNeurology international
researchProduct

Metalloproteinases and Tissue Inhibitors in Generalized Myasthenia Gravis. A Preliminary Study

2022

Introduction: Matrix metalloproteinases (MMPs) and tissue inhibitors of metalloproteinases (TIMPs) have recently been proposed as promising biomarkers in different immune-mediated disorders. We evaluated the plasma levels of MMP-9 and MMP-2 and their tissue inhibitors TIMP-1 and TIMP-2 in a patients’ cohort with generalized myasthenia gravis (MG). Methods: Plasma concentrations of MMP-9, MMP-2, TIMP-1 and TIMP-2 were evaluated in 14 patients with generalized MG and 13 age- and sex-matched healthy controls. The severity of disease was assessed by the modified Osserman classification. Results: Compared to the healthy subjects, MG patients had increased plasma concentrations of MMP-9, but redu…

neuromuscular junction.matrix metalloproteinases; anti-AChR antibodies; myasthenia gravis; neuromuscular junctionmatrix metalloproteinaseGeneral Neuroscienceanti-AChR antibodiemyasthenia gravi
researchProduct

Uniportal bilateral video-assisted sequential thoracoscopic extended thymectomy

2017

Standard video-assisted thoracoscopic surgery has been reported as a minimally invasive approach alternative to sternotomy for management of myasthenia gravis (MG) associated with thymoma or thymic hyperplasia. Uniportal video-thoracoscopy is an evolution of standard multi-portal video-thoracoscopy for management of several thoracic diseases but its role for resecting mediastinal tumor remains under-evaluated. Herein, we describe our experience with bilateral uniportal thoracoscopic sequential extended thymectomy with case and video illustrations.

uniportal video-assisted thoracic surgery (uniportal VATS)medicine.medical_specialtythymus glandThymomabusiness.industrymedicine.medical_treatmentSettore MED/21 - Chirurgia ToracicaMediastinal tumorExtended thymectomyMyasthenia gravis (MG); thymectomy; thymus gland; thoracoscopic thymectomy; uniportal videoassisted thoracic surgery (uniportal VATS)medicine.diseaseMyasthenia gravisSurgeryThymectomyuniportal videoassisted thoracic surgery (uniportal VATS)Settore MED/18 - Chirurgia Generalethoracoscopic thymectomyMyasthenia gravis (MG)Thoracic diseasesReview Article on Thoracic SurgeryMedicineVideo assistedThoracoscopic thymectomybusinessthymectomy
researchProduct